Cancer

Main Content

GBM

Study title

Standard Chemotherapy vs Chemotherapy Chosen by Cancer Stem Cell Chemosensitivity Testing in the Management of Patients with Recurrent Glioblastoma Multiforme (GBM)

  • Principal Investigator: Dr. Mark Anderson

Purpose 

The purpose of this study is to screen chemotherapy drugs that are currently being used for the care of recurrent glioblastoma (a form of brain cancer) and to determine the most effective treatment.

Who can participate 

Those eligible to participate in this study include:

  • Men and women with glioblastoma and who are ages 18 and older

For more information

  • Jennifer Barnes
    University of Mississippi Medical Center
    2500 N. State St.
    Jackson, MS 39216
    (601) 984-1965
  • IRB Number: 2018-0139